The estimated Net Worth of Amanda L. De Palma is at least $26.9 millier dollars as of 1 June 2016. Amanda Palma owns over 689 units of Endologix stock worth over $9,630 and over the last 9 years Amanda sold ELGX stock worth over $17,294.
Amanda has made over 2 trades of the Endologix stock since 2016, according to the Form 4 filled with the SEC. Most recently Amanda sold 689 units of ELGX stock worth $8,647 on 1 June 2016.
The largest trade Amanda's ever made was selling 689 units of Endologix stock on 1 June 2016 worth over $8,647. On average, Amanda trades about 345 units every 0 days since 2015. As of 1 June 2016 Amanda still owns at least 43,772 units of Endologix stock.
You can see the complete history of Amanda Palma stock trades at the bottom of the page.
Amanda's mailing address filed with the SEC is 2, Musick, Irvine Spectrum, Irvine, Orange, California, 92618, United States of America.
Over the last 22 years, insiders at Endologix have traded over $72,068,611 worth of Endologix stock and bought 306,824 units worth $2,023,811 . The most active insiders traders include International, L.P. Elliott, Associates, L.P. Elliott et Capital Management Lp Camber. On average, Endologix executives and independent directors trade stock every 27 days with the average trade being worth of $13,088. The most recent stock trade was executed by Dan Lemaitre on 4 September 2020, trading 51,844 units of ELGX stock currently worth $2,592.
Endologix, Inc. engages in the research, development, manufacture, and trade of medical devices for the treatment of aortic disorders such as abdominal aortic aneurysms (AAA). Its products include AFX Endovascular AAA System, Nellix and Ovation. The company was founded in March 1992 and is headquartered in Irvine, CA.
Endologix executives and other stock owners filed with the SEC include: